_id
691b15853c536f8df2318b7d
Ticker
GNRO.PA
Name
Geneuro SA
Exchange
PA
Address
3 chemin du Pré-Fleur, Plan-les-Ouates, Switzerland, 1228
Country
France
Sector
Healthcare
Industry
Biotechnology
Currency
EUR
Website
https://www.geneuro.com
Description
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family that has completed a Phase II clinical trials. It is also developing GNC-501 for post-COVID on patients with persistent neuropsychiatric syndromes that is in Phase 2 clinical trials; and GNK301 for sporadic amyotrophic lateral sclerosis which is in preclinical development program. In addition, the company has a collaborative development agreement with The National Institute of Neurological Disorders and Strokes for the development of an antibody program to block the activity of pHERV-K Env; and FondaMental Foundation for the development of diagnostic and therapeutic options for patients with Post-COVID neuropsychiatric syndromes, as well as research collaboration agreement with Northwestern University to confirm evidence of the expression of human endogenous retrovirus W envelope protein (W-ENV or W-ENV) in long-haul COVID patients; and US National Institute of Health for developing new approaches against pHERV-K (K-ENV) protein as a target in the treatment of amyotrophic lateral sclerosis. GeNeuro SA was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
Last Close
0.0356
Volume
110893
Current Price
0.0268
Change
-0.0026
Last Updated
2025-12-31T15:55:00.019Z
Image
https://logo.clearbit.com/www.geneuro.com
Ipo Date
-
Market Cap
1006270
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2023-12-31
Revenue
0
Cost Of Revenue
146400
Gross Profit
-146400
Operating Expenses
7571900
Operating Income
-7580400
Interest Expense
566700
Pretax Income
-8179500
Net Income
-7894.9
Eps
-0.0003178941010670425
Dividends Per Share
-
Shares Outstanding
29596194
Income Tax Expense
-284600
EBITDA
-7466400
Operating Margin
-
Total Other Income Expense Net
-599100
Cash
1827400
Short Term Investments
-
Receivables
162100
Inventories
-
Total Current Assets
2334400
Property Plant Equipment
742100
Total Assets
6361900
Payables
2459600
Short Term Debt
747300
Long Term Debt
12121900
Total Liabilities
20139900
Equity
-13778000
Bs_currency_symbol
EUR
Depreciation
146400
Change In Working Capital
921.8
Cash From Operations
-5421500
Capital Expenditures
25000
Cash From Investing
-12500
Cash From Financing
-269999
Net Change In Cash
-5571000
Cf_currency_symbol
EUR
PE
-
PB
-0.04830730149513718
ROE
0.05730076934242996
ROA
-0.12409657492258601
FCF
-5446500
Fcf Percent
-
Piotroski FScore
0
Health Score
23
Deep Value Investing Score
2
Defensive Investing Score
5.5
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
0.5
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
2
Quality Investing Score
0.5
Value Investing Score
0.5
Quarters > 0 > quarter
2023-12-31
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
146400
Quarters > 0 > income Statement > gross Profit
-146400
Quarters > 0 > income Statement > operating Expenses
7571900
Quarters > 0 > income Statement > operating Income
-7580400
Quarters > 0 > income Statement > interest Expense
566700
Quarters > 0 > income Statement > pretax Income
-8179500
Quarters > 0 > income Statement > net Income
-7894.9
Quarters > 0 > income Statement > eps
-0.0003178941010670425
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
24835000
Quarters > 0 > income Statement > income Tax Expense
-284600
Quarters > 0 > income Statement > EBITDA
-7466400
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-599100
Quarters > 0 > income Statement > currency_symbol
EUR
Quarters > 0 > balance Sheet > cash
1827400
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
162100
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
2334400
Quarters > 0 > balance Sheet > property Plant Equipment
742100
Quarters > 0 > balance Sheet > total Assets
6361900
Quarters > 0 > balance Sheet > payables
2459600
Quarters > 0 > balance Sheet > short Term Debt
747300
Quarters > 0 > balance Sheet > long Term Debt
12121900
Quarters > 0 > balance Sheet > total Liabilities
20139900
Quarters > 0 > balance Sheet > equity
-13778000
Quarters > 0 > balance Sheet > currency_symbol
EUR
Quarters > 0 > cash Flow > net Income
-7894.9
Quarters > 0 > cash Flow > depreciation
146400
Quarters > 0 > cash Flow > change In Working Capital
921.8
Quarters > 0 > cash Flow > cash From Operations
-5421500
Quarters > 0 > cash Flow > capital Expenditures
25000
Quarters > 0 > cash Flow > cash From Investing
-12500
Quarters > 0 > cash Flow > cash From Financing
-269999
Quarters > 0 > cash Flow > net Change In Cash
-5571000
Quarters > 0 > cash Flow > currency_symbol
EUR
Quarters > 0 > ratios > PE
-0.0003178941010670425
Quarters > 0 > ratios > PB
-0.04830730149513718
Quarters > 0 > ratios > ROE
0.05730076934242996
Quarters > 0 > ratios > ROA
-0.12409657492258601
Quarters > 0 > ratios > FCF
-5446500
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
23
Quarters > 1 > quarter
2023-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
147400
Quarters > 1 > income Statement > gross Profit
-147400
Quarters > 1 > income Statement > operating Expenses
7635000
Quarters > 1 > income Statement > operating Income
-7782400
Quarters > 1 > income Statement > interest Expense
385900
Quarters > 1 > income Statement > pretax Income
-7129200
Quarters > 1 > income Statement > net Income
-6862100
Quarters > 1 > income Statement > eps
-0.27612332207328333
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
24851577
Quarters > 1 > income Statement > income Tax Expense
-267100
Quarters > 1 > income Statement > EBITDA
-6595900
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
653200
Quarters > 1 > income Statement > currency_symbol
EUR
Quarters > 1 > balance Sheet > cash
7398400
Quarters > 1 > balance Sheet > short Term Investments
-209500
Quarters > 1 > balance Sheet > receivables
1430300
Quarters > 1 > balance Sheet > inventories
423700
Quarters > 1 > balance Sheet > total Current Assets
9709300
Quarters > 1 > balance Sheet > property Plant Equipment
888400
Quarters > 1 > balance Sheet > total Assets
12207900
Quarters > 1 > balance Sheet > payables
1818100
Quarters > 1 > balance Sheet > short Term Debt
658200
Quarters > 1 > balance Sheet > long Term Debt
5509900
Quarters > 1 > balance Sheet > total Liabilities
17799700
Quarters > 1 > balance Sheet > equity
-5591800
Quarters > 1 > balance Sheet > currency_symbol
EUR
Quarters > 1 > cash Flow > net Income
-6862100
Quarters > 1 > cash Flow > depreciation
147400
Quarters > 1 > cash Flow > change In Working Capital
2438400
Quarters > 1 > cash Flow > cash From Operations
-4684500
Quarters > 1 > cash Flow > capital Expenditures
12500
Quarters > 1 > cash Flow > cash From Investing
-12500
Quarters > 1 > cash Flow > cash From Financing
6628000
Quarters > 1 > cash Flow > net Change In Cash
1805100
Quarters > 1 > cash Flow > currency_symbol
EUR
Quarters > 1 > ratios > PE
-0.27612332207328333
Quarters > 1 > ratios > PB
-0.11910695368217747
Quarters > 1 > ratios > ROE
122.71719303265496
Quarters > 1 > ratios > ROA
-56.21032282374529
Quarters > 1 > ratios > FCF
-4697000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2023-03-31
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
1300
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
EUR
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
1328000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
9709300
Quarters > 2 > balance Sheet > property Plant Equipment
888400
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
1818100
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
4665500
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
EUR
Quarters > 2 > cash Flow > net Income
-3431050
Quarters > 2 > cash Flow > depreciation
73750
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-2359850
Quarters > 2 > cash Flow > capital Expenditures
6250
Quarters > 2 > cash Flow > cash From Investing
20000
Quarters > 2 > cash Flow > cash From Financing
3305350
Quarters > 2 > cash Flow > net Change In Cash
902550
Quarters > 2 > cash Flow > currency_symbol
EUR
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-2366100
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2022-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
144500
Quarters > 3 > income Statement > gross Profit
-144500
Quarters > 3 > income Statement > operating Expenses
6772800
Quarters > 3 > income Statement > operating Income
-6917300
Quarters > 3 > income Statement > interest Expense
156100
Quarters > 3 > income Statement > pretax Income
-6870600
Quarters > 3 > income Statement > net Income
-6524400
Quarters > 3 > income Statement > eps
-0.26264266733265285
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
24841356
Quarters > 3 > income Statement > income Tax Expense
-346200
Quarters > 3 > income Statement > EBITDA
-6570000
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
46700
Quarters > 3 > income Statement > currency_symbol
EUR
Quarters > 3 > balance Sheet > cash
5593300
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
1481800
Quarters > 3 > balance Sheet > inventories
1396800
Quarters > 3 > balance Sheet > total Current Assets
9088300
Quarters > 3 > balance Sheet > property Plant Equipment
992900
Quarters > 3 > balance Sheet > total Assets
11420100
Quarters > 3 > balance Sheet > payables
764.8
Quarters > 3 > balance Sheet > short Term Debt
601800
Quarters > 3 > balance Sheet > long Term Debt
5647700
Quarters > 3 > balance Sheet > total Liabilities
10006800
Quarters > 3 > balance Sheet > equity
1413300
Quarters > 3 > balance Sheet > currency_symbol
EUR
Quarters > 3 > cash Flow > net Income
-6524400
Quarters > 3 > cash Flow > depreciation
144500
Quarters > 3 > cash Flow > change In Working Capital
-3915900
Quarters > 3 > cash Flow > cash From Operations
-10546700
Quarters > 3 > cash Flow > capital Expenditures
40000
Quarters > 3 > cash Flow > cash From Investing
-40000
Quarters > 3 > cash Flow > cash From Financing
5182000
Quarters > 3 > cash Flow > net Change In Cash
-5405200
Quarters > 3 > cash Flow > currency_symbol
EUR
Quarters > 3 > ratios > PE
-0.26264266733265285
Quarters > 3 > ratios > PB
0.471059464232647
Quarters > 3 > ratios > ROE
-461.64296327743574
Quarters > 3 > ratios > ROA
-57.13084824125884
Quarters > 3 > ratios > FCF
-10586700
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
23
Annuals > 0 > quarter
2023-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
293800
Annuals > 0 > income Statement > gross Profit
-293800
Annuals > 0 > income Statement > operating Expenses
15206900
Annuals > 0 > income Statement > operating Income
-14357300
Annuals > 0 > income Statement > interest Expense
952600
Annuals > 0 > income Statement > pretax Income
-15308700
Annuals > 0 > income Statement > net Income
-14757000
Annuals > 0 > income Statement > eps
-0.5940008450534486
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
24843399
Annuals > 0 > income Statement > income Tax Expense
-551700
Annuals > 0 > income Statement > EBITDA
-14317700
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-951400
Annuals > 0 > income Statement > currency_symbol
EUR
Annuals > 0 > balance Sheet > cash
1827400
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
162100
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
2334400
Annuals > 0 > balance Sheet > property Plant Equipment
742100
Annuals > 0 > balance Sheet > total Assets
6361900
Annuals > 0 > balance Sheet > payables
2459600
Annuals > 0 > balance Sheet > short Term Debt
747300
Annuals > 0 > balance Sheet > long Term Debt
12121900
Annuals > 0 > balance Sheet > total Liabilities
20139900
Annuals > 0 > balance Sheet > equity
-13778000
Annuals > 0 > balance Sheet > currency_symbol
EUR
Annuals > 0 > cash Flow > net Income
-14757000
Annuals > 0 > cash Flow > depreciation
293800
Annuals > 0 > cash Flow > change In Working Capital
3948700
Annuals > 0 > cash Flow > cash From Operations
-10147000
Annuals > 0 > cash Flow > capital Expenditures
25000
Annuals > 0 > cash Flow > cash From Investing
50800
Annuals > 0 > cash Flow > cash From Financing
6323200
Annuals > 0 > cash Flow > net Change In Cash
-3765900
Annuals > 0 > cash Flow > currency_symbol
EUR
Annuals > 0 > ratios > PE
-0.5940008450534486
Annuals > 0 > ratios > PB
-0.05661799452750762
Annuals > 0 > ratios > ROE
107.10553055595878
Annuals > 0 > ratios > ROA
-231.9590059573398
Annuals > 0 > ratios > FCF
-10172000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
30
Annuals > 1 > quarter
2022-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
288500
Annuals > 1 > income Statement > gross Profit
-288500
Annuals > 1 > income Statement > operating Expenses
12766500
Annuals > 1 > income Statement > operating Income
-13055000
Annuals > 1 > income Statement > interest Expense
269300
Annuals > 1 > income Statement > pretax Income
-13514100
Annuals > 1 > income Statement > net Income
-12199800
Annuals > 1 > income Statement > eps
-0.5104878305865639
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
23898317
Annuals > 1 > income Statement > income Tax Expense
-1314300
Annuals > 1 > income Statement > EBITDA
-12956300
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-459100
Annuals > 1 > income Statement > currency_symbol
EUR
Annuals > 1 > balance Sheet > cash
5593300
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1481800
Annuals > 1 > balance Sheet > inventories
1396800
Annuals > 1 > balance Sheet > total Current Assets
9088300
Annuals > 1 > balance Sheet > property Plant Equipment
992900
Annuals > 1 > balance Sheet > total Assets
11420100
Annuals > 1 > balance Sheet > payables
764.8
Annuals > 1 > balance Sheet > short Term Debt
601800
Annuals > 1 > balance Sheet > long Term Debt
5647700
Annuals > 1 > balance Sheet > total Liabilities
10006800
Annuals > 1 > balance Sheet > equity
1413300
Annuals > 1 > balance Sheet > currency_symbol
EUR
Annuals > 1 > cash Flow > net Income
-12199800
Annuals > 1 > cash Flow > depreciation
288500
Annuals > 1 > cash Flow > change In Working Capital
-1881300
Annuals > 1 > cash Flow > cash From Operations
-13072500
Annuals > 1 > cash Flow > capital Expenditures
57400
Annuals > 1 > cash Flow > cash From Investing
-57400
Annuals > 1 > cash Flow > cash From Financing
13117300
Annuals > 1 > cash Flow > net Change In Cash
113800
Annuals > 1 > cash Flow > currency_symbol
EUR
Annuals > 1 > ratios > PE
-0.5104878305865639
Annuals > 1 > ratios > PB
0.5309609805419938
Annuals > 1 > ratios > ROE
-863.2137550413925
Annuals > 1 > ratios > ROA
-106.82743583681405
Annuals > 1 > ratios > FCF
-13129900
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
16
Annuals > 2 > quarter
2021-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
300200
Annuals > 2 > income Statement > gross Profit
-300200
Annuals > 2 > income Statement > operating Expenses
7239000
Annuals > 2 > income Statement > operating Income
-7539200
Annuals > 2 > income Statement > interest Expense
40600
Annuals > 2 > income Statement > pretax Income
-7824700
Annuals > 2 > income Statement > net Income
-6817700
Annuals > 2 > income Statement > eps
-0.3203805035984712
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
21280009
Annuals > 2 > income Statement > income Tax Expense
-1007000
Annuals > 2 > income Statement > EBITDA
-7483900
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-285500
Annuals > 2 > income Statement > currency_symbol
EUR
Annuals > 2 > balance Sheet > cash
5479500
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1233000
Annuals > 2 > balance Sheet > inventories
166100
Annuals > 2 > balance Sheet > total Current Assets
9870100
Annuals > 2 > balance Sheet > property Plant Equipment
1218400
Annuals > 2 > balance Sheet > total Assets
12421000
Annuals > 2 > balance Sheet > payables
581.4
Annuals > 2 > balance Sheet > short Term Debt
256900
Annuals > 2 > balance Sheet > long Term Debt
2534500
Annuals > 2 > balance Sheet > total Liabilities
7694500
Annuals > 2 > balance Sheet > equity
4726500
Annuals > 2 > balance Sheet > currency_symbol
EUR
Annuals > 2 > cash Flow > net Income
-6817700
Annuals > 2 > cash Flow > depreciation
300200
Annuals > 2 > cash Flow > change In Working Capital
-470000
Annuals > 2 > cash Flow > cash From Operations
-6784700
Annuals > 2 > cash Flow > capital Expenditures
43600
Annuals > 2 > cash Flow > cash From Investing
-43600
Annuals > 2 > cash Flow > cash From Financing
5390800
Annuals > 2 > cash Flow > net Change In Cash
-1363400
Annuals > 2 > cash Flow > currency_symbol
EUR
Annuals > 2 > ratios > PE
-0.3203805035984712
Annuals > 2 > ratios > PB
0.14137147627208294
Annuals > 2 > ratios > ROE
-144.24415529461547
Annuals > 2 > ratios > ROA
-54.88849529023428
Annuals > 2 > ratios > FCF
-6828300
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
23
Annuals > 3 > quarter
2020-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
334600
Annuals > 3 > income Statement > gross Profit
-334600
Annuals > 3 > income Statement > operating Expenses
7705900
Annuals > 3 > income Statement > operating Income
-8040500
Annuals > 3 > income Statement > interest Expense
80200
Annuals > 3 > income Statement > pretax Income
-9516200
Annuals > 3 > income Statement > net Income
-8962300
Annuals > 3 > income Statement > eps
-0.44880407133091793
Annuals > 3 > income Statement > dividends Per Share
327457.2
Annuals > 3 > income Statement > shares Outstanding
19969293
Annuals > 3 > income Statement > income Tax Expense
-553900
Annuals > 3 > income Statement > EBITDA
-9101400
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-1475700
Annuals > 3 > income Statement > currency_symbol
EUR
Annuals > 3 > balance Sheet > cash
6842900
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
668700
Annuals > 3 > balance Sheet > inventories
151000
Annuals > 3 > balance Sheet > total Current Assets
7662800
Annuals > 3 > balance Sheet > property Plant Equipment
1442000
Annuals > 3 > balance Sheet > total Assets
10435900
Annuals > 3 > balance Sheet > payables
540400
Annuals > 3 > balance Sheet > short Term Debt
293300
Annuals > 3 > balance Sheet > long Term Debt
129800
Annuals > 3 > balance Sheet > total Liabilities
4996300
Annuals > 3 > balance Sheet > equity
5514500
Annuals > 3 > balance Sheet > currency_symbol
EUR
Annuals > 3 > cash Flow > net Income
-8962300
Annuals > 3 > cash Flow > depreciation
361800
Annuals > 3 > cash Flow > change In Working Capital
-397500
Annuals > 3 > cash Flow > cash From Operations
-7173500
Annuals > 3 > cash Flow > capital Expenditures
23300
Annuals > 3 > cash Flow > cash From Investing
-22800
Annuals > 3 > cash Flow > cash From Financing
8148700
Annuals > 3 > cash Flow > net Change In Cash
911500
Annuals > 3 > cash Flow > currency_symbol
EUR
Annuals > 3 > ratios > PE
-0.44880407133091793
Annuals > 3 > ratios > PB
0.11370673682110796
Annuals > 3 > ratios > ROE
-162.5224408377913
Annuals > 3 > ratios > ROA
-85.87951206891596
Annuals > 3 > ratios > FCF
-7196800
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
29
Valuation > metrics > PE
-0.0003178941010670425
Valuation > metrics > PB
-0.04830730149513718
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
0.05730076934242996
Profitability > metrics > ROA
-0.3381982522275531
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-13.376389624139756
Risk > final Score
-24
Risk > verdict
High
Liquidity > metrics > Current Ratio
0.7279304000748387
Liquidity > metrics > Quick Ratio
0.7279304000748387
Liquidity > final Score
46
Liquidity > verdict
Weak
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
70
Prev Profitabilities > 0
55
Prev Profitabilities > 1
50
Prev Profitabilities > 2
15
Prev Risks > 0
-51
Prev Risks > 1
50
Prev Risks > 2
-171
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-22T21:22:18.784Z
Earnings History > 0 > period
2024-09-30
Earnings History > 0 > report Date
2024-11-27
Earnings History > 0 > date
2024-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
0
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2024-06-30
Earnings History > 1 > report Date
2024-09-30
Earnings History > 1 > date
2024-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
0
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Earnings History > 2 > period
2024-03-31
Earnings History > 2 > report Date
2024-04-29
Earnings History > 2 > date
2024-03-31
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.32
Earnings History > 2 > eps Estimate
0
Earnings History > 2 > eps Difference
-0.32
Earnings History > 2 > surprise Percent
-
Earnings History > 3 > period
2023-09-30
Earnings History > 3 > report Date
2023-12-29
Earnings History > 3 > date
2023-09-30
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
EUR
Earnings History > 3 > eps Actual
0
Earnings History > 3 > eps Estimate
0
Earnings History > 3 > eps Difference
0
Earnings History > 3 > surprise Percent
-
Earnings History > 4 > period
2023-06-30
Earnings History > 4 > report Date
2023-07-25
Earnings History > 4 > date
2023-06-30
Earnings History > 4 > before After Market
AfterMarket
Earnings History > 4 > currency
EUR
Earnings History > 4 > eps Actual
0
Earnings History > 4 > eps Estimate
0
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
-
Earnings History > 5 > period
2023-03-31
Earnings History > 5 > report Date
2023-04-05
Earnings History > 5 > date
2023-03-31
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
EUR
Earnings History > 5 > eps Actual
-0.26
Earnings History > 5 > eps Estimate
0
Earnings History > 5 > eps Difference
-0.26
Earnings History > 5 > surprise Percent
-
Earnings History > 6 > period
2022-09-30
Earnings History > 6 > report Date
2022-10-24
Earnings History > 6 > date
2022-09-30
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
EUR
Earnings History > 6 > eps Actual
0
Earnings History > 6 > eps Estimate
0
Earnings History > 6 > eps Difference
0
Earnings History > 6 > surprise Percent
-
Earnings History > 7 > period
2022-06-30
Earnings History > 7 > report Date
2022-07-21
Earnings History > 7 > date
2022-06-30
Earnings History > 7 > before After Market
AfterMarket
Earnings History > 7 > currency
EUR
Earnings History > 7 > eps Actual
-0.25
Earnings History > 7 > eps Estimate
-
Earnings History > 7 > eps Difference
0
Earnings History > 7 > surprise Percent
-
Earnings History > 8 > period
2022-03-31
Earnings History > 8 > report Date
2022-04-05
Earnings History > 8 > date
2022-03-31
Earnings History > 8 > before After Market
AfterMarket
Earnings History > 8 > currency
EUR
Earnings History > 8 > eps Actual
-0.15
Earnings History > 8 > eps Estimate
0
Earnings History > 8 > eps Difference
-0.15
Earnings History > 8 > surprise Percent
-
Earnings History > 9 > period
2021-09-30
Earnings History > 9 > report Date
2021-12-01
Earnings History > 9 > date
2021-09-30
Earnings History > 9 > before After Market
-
Earnings History > 9 > currency
EUR
Earnings History > 9 > eps Actual
0
Earnings History > 9 > eps Estimate
0
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2021-06-30
Earnings History > 10 > report Date
2021-09-22
Earnings History > 10 > date
2021-06-30
Earnings History > 10 > before After Market
AfterMarket
Earnings History > 10 > currency
EUR
Earnings History > 10 > eps Actual
-0.17
Earnings History > 10 > eps Estimate
-
Earnings History > 10 > eps Difference
0
Earnings History > 10 > surprise Percent
-
Earnings History > 11 > period
2021-03-31
Earnings History > 11 > report Date
2021-04-06
Earnings History > 11 > date
2021-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
EUR
Earnings History > 11 > eps Actual
-0.24
Earnings History > 11 > eps Estimate
0
Earnings History > 11 > eps Difference
-0.24
Earnings History > 11 > surprise Percent
-
Earnings History > 12 > period
2020-09-30
Earnings History > 12 > report Date
2020-11-17
Earnings History > 12 > date
2020-09-30
Earnings History > 12 > before After Market
AfterMarket
Earnings History > 12 > currency
EUR
Earnings History > 12 > eps Actual
0
Earnings History > 12 > eps Estimate
0
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
-
Earnings History > 13 > period
2020-06-30
Earnings History > 13 > report Date
2020-07-24
Earnings History > 13 > date
2020-06-30
Earnings History > 13 > before After Market
AfterMarket
Earnings History > 13 > currency
EUR
Earnings History > 13 > eps Actual
-0.2
Earnings History > 13 > eps Estimate
0
Earnings History > 13 > eps Difference
-0.2
Earnings History > 13 > surprise Percent
-
Earnings History > 14 > period
2020-03-31
Earnings History > 14 > report Date
2020-04-07
Earnings History > 14 > date
2020-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
EUR
Earnings History > 14 > eps Actual
-0.34
Earnings History > 14 > eps Estimate
0
Earnings History > 14 > eps Difference
-0.34
Earnings History > 14 > surprise Percent
-
Earnings History > 15 > period
2019-09-30
Earnings History > 15 > report Date
2019-10-25
Earnings History > 15 > date
2019-09-30
Earnings History > 15 > before After Market
AfterMarket
Earnings History > 15 > currency
EUR
Earnings History > 15 > eps Actual
0
Earnings History > 15 > eps Estimate
0
Earnings History > 15 > eps Difference
0
Earnings History > 15 > surprise Percent
-
Earnings History > 16 > period
2019-06-30
Earnings History > 16 > report Date
2019-09-30
Earnings History > 16 > date
2019-06-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
EUR
Earnings History > 16 > eps Actual
-0.31
Earnings History > 16 > eps Estimate
0
Earnings History > 16 > eps Difference
-0.31
Earnings History > 16 > surprise Percent
-
Earnings History > 17 > period
2019-03-31
Earnings History > 17 > report Date
2019-04-01
Earnings History > 17 > date
2019-03-31
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
EUR
Earnings History > 17 > eps Actual
-0.41
Earnings History > 17 > eps Estimate
0
Earnings History > 17 > eps Difference
-0.41
Earnings History > 17 > surprise Percent
-
Earnings History > 18 > period
2018-09-30
Earnings History > 18 > report Date
2018-10-24
Earnings History > 18 > date
2018-09-30
Earnings History > 18 > before After Market
AfterMarket
Earnings History > 18 > currency
EUR
Earnings History > 18 > eps Actual
0
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
0
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2018-06-30
Earnings History > 19 > report Date
2018-07-26
Earnings History > 19 > date
2018-06-30
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
EUR
Earnings History > 19 > eps Actual
-0.16
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.16
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2018-03-31
Earnings History > 20 > report Date
2018-04-03
Earnings History > 20 > date
2018-03-31
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
EUR
Earnings History > 20 > eps Actual
0.15
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
0.15
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2017-06-30
Earnings History > 21 > report Date
2017-07-31
Earnings History > 21 > date
2017-06-30
Earnings History > 21 > before After Market
AfterMarket
Earnings History > 21 > currency
EUR
Earnings History > 21 > eps Actual
-0.55
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.55
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2016-09-30
Earnings History > 22 > report Date
2016-10-24
Earnings History > 22 > date
2016-09-30
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
EUR
Earnings History > 22 > eps Actual
0
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
0
Earnings History > 22 > surprise Percent
-
GeNeuro SA, a clinical-stage biopharmaceutical company, develops drugs for the treatment of neurodegenerative and autoimmune diseases. The company's lead therapeutic candidate is temelimab, a monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family that has completed a Phase II clinical trials. It is also developing GNC-501 for post-COVID on patients with persistent neuropsychiatric syndromes that is in Phase 2 clinical trials; and GNK301 for sporadic amyotrophic lateral sclerosis which is in preclinical development program. In addition, the company has a collaborative development agreement with The National Institute of Neurological Disorders and Strokes for the development of an antibody program to block the activity of pHERV-K Env; and FondaMental Foundation for the development of diagnostic and therapeutic options for patients with Post-COVID neuropsychiatric syndromes, as well as research collaboration agreement with Northwestern University to confirm evidence of the expression of human endogenous retrovirus W envelope protein (W-ENV or W-ENV) in long-haul COVID patients; and US National Institute of Health for developing new approaches against pHERV-K (K-ENV) protein as a target in the treatment of amyotrophic lateral sclerosis. GeNeuro SA was incorporated in 2006 and is headquartered in Plan-les-Ouates, Switzerland.
Stock Price
€0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2023-12-31)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 0.00% of the total shares of Geneuro SA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2024-09-30
EPS Actual
0
EPS Estimate
0
EPS Difference
0
Surprise Percent
0%
(Last Updated 2023-12-31)
(Last Updated 2023-12-31)
Revenue
€ 0
Cost Of Revenue
€ 0
Gross Profit
€ 0
Operating Expenses
€ 0
Operating Income
€ 0
Interest Expense
€ 0
Pretax Income
€ 0
Net Income
€ 0
Income Tax Expense
€ 0
EBITDA
€ 0
Total Other Income Expense Net
€ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2023-12-31)
Cash
€ 0
Short Term Investments
€ 0
Receivables
€ 0
Inventories
€ 0
Total Current Assets
€ 0
Property Plant Equipment
€ 0
Total Assets
€ 0
Payables
€ 0
Short Term Debt
€ 0
Long Term Debt
€ 0
Total Liabilities
€ 0
Equity
€ 0
(Last Updated 2023-12-31)
Net Income
€ 0
Depreciation
€ 0
Change In Working Capital
€ 0
Cash From Operations
€ 0
Capital Expenditures
€ 0
Cash From Investing
€ 0
Cash From Financing
€ 0
Net Change In Cash
€ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.